Ublituximab

ATC L04AG14 · 5 markets · 7 records

Ublituximab 5 markets · 7 records Forms

AU 3 records · 3 strengths

  • 150 mg/6 mLinjectionBRIUMVI also in US·GB
  • 25 mg/mLinjectionBRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 150 mg/6 mLinjectionBriumvi 150mg/6ml concentrate for solution for infusion vials also in AU·US

ES 1 records · 1 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

    Side-by-side table

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.